Therapy strategies for multiple myeloma: current status. [electronic resource]
Producer: 20031205Description: 451-61 p. digitalISSN:- 0043-5325
- Adjuvants, Immunologic -- therapeutic use
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Antineoplastic Agents -- therapeutic use
- Arsenic Trioxide
- Arsenicals -- therapeutic use
- Bone Marrow Transplantation
- Boronic Acids -- therapeutic use
- Bortezomib
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Dexamethasone -- administration & dosage
- Diphosphonates -- therapeutic use
- Drug Therapy, Combination
- Erythropoietin -- therapeutic use
- Glucocorticoids -- administration & dosage
- Growth Inhibitors -- therapeutic use
- Humans
- Immunosuppressive Agents -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Oxides -- therapeutic use
- Peripheral Blood Stem Cell Transplantation
- Protease Inhibitors -- therapeutic use
- Pyrazines -- therapeutic use
- Randomized Controlled Trials as Topic
- Stem Cell Transplantation
- Thalidomide -- administration & dosage
- Time Factors
- Transplantation, Autologous
- Transplantation, Homologous
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.